feed,title,long_url,short_url
Benzinga,"The Daily Biotech Pulse: Sanofi, GSK Begin Phase 1/2 Coronavirus Vaccine Study, Fulgent Strikes COVID-19 Testing Deal, New Data From Novavax",https://www.benzinga.com/general/biotech/20/09/17365749/the-daily-biotech-pulse-sanofi-gsk-begin-phase-12-coronavirus-vaccine-study-fulgent-strikes-covid,https://j.mp/2R3UugZ
